Merck & Co., Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2095
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:505
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Merck & Co., Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Merck & Co., Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Merck & Co., Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Merck & Co., Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Merck & Co., Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Merck & Co., Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Merck & Co., Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Merck & Co., Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Merck & Co., Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Overview 7
Mergers and Acquisitions – Deal reports 8
CORPORATE VENTURING 20
Corporate Venturing – Overview 20
Corporate Venturing – Deal reports 21
PARTNERSHIP 32
Partnership – Overview 32
Partnership – Deal reports 33
DIVESTMENTS 474
Divestments – Overview 474
Divestments – Deal reports 475
APPENDIX 495
Contact Us 495
About MarketLine Financial Deals Database 495
Deal Definition and Methodology 497
About MarketLine 504

List of Tables
Table 1: Merck & Co. M&A volume and value trend (2014-YTD2018)
Table 2: Merck & Co. M&A activity by geography (2014-YTD2018)
Table 3: Merck & Co. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Merck & Co. corporate venturing by geography (2014-YTD2018)
Table 5: Merck & Co. partnership volume and value trend (2014-YTD2018)
Table 6: Merck & Co. partnership trend by key deal type (2014-YTD2018)
Table 7: Merck & Co. divestments volume and value trend (2014-YTD2018)
Table 8: Merck & Co. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Merck & Co. M&A volume and value trend (2014-YTD2018)
Figure 2: Merck & Co. M&A activity by geography (2014-YTD2018)
Figure 3: Merck & Co. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Merck & Co. corporate venturing by geography (2014-YTD2018)
Figure 5: Merck & Co. partnership volume and value trend (2014-YTD2018)
Figure 6: Merck & Co. partnership trend by key deal type (2014-YTD2018)
Figure 7: Merck & Co. divestments volume and value trend (2014-YTD2018)
Figure 8: Merck & Co. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Merck & Co., Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Globus Medical, Inc. (GMED)-医療機器分野:企業M&A・提携分析
    Summary Globus Medical, Inc. (Globus) is a medical device company which manufactures and markets musculoskeletal implants with focus on the treatment of spine disorders. The company’s product portfolio includes biomaterial products, cervical, deformity, intervertebral fusion, minimally invasive, mot …
  • Centrexion Therapeutics Corp (CNTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …
  • Rad Source Technologies Inc:企業の戦略的SWOT分析
    Rad Source Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Nakanishi Inc (7716):企業の財務・戦略的SWOT分析
    Nakanishi Inc (7716) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SINTX Technologies Inc (SINT):企業の財務・戦略的SWOT分析
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • HepQuant Llc:製品パイプライン分析
    Summary Hepquant LLC (Hepquant) is a medical device company that provides diagnostic products. The company develops and markets products for measuring liver function. It offers products such as hepquant-stat, hepquant-shunt, and hepquant-flow. Hepquant’s hepquant-STAT is used in screening assay to i …
  • UnitedHealth Group Inc (UNH):企業の財務・戦略的SWOT分析
    UnitedHealth Group Inc (UNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Granules India Ltd (GRANULES):企業の財務・戦略的SWOT分析
    Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務分析
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • The Indian Hotels Company Limited:企業の戦略・SWOT・財務情報
    The Indian Hotels Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Indian Hotels Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Public Power Corporation SA (PPC)-エネルギー分野:企業M&A・提携分析
    Summary Public Power Corporation S.A. (PPC) is power producer and electricity supply company. The company designs, constructs, maintains and operates power plants. It also generates, transmits and distributes electricity. The company generates power from lignite, fuel oil, and natural gas based plan …
  • G-III Apparel Group Ltd (GIII):企業の財務・戦略的SWOT分析
    Summary G-III Apparel Group, Ltd. (G-III or “the company”) is an apparel and footwear manufacturing company. The company designs, manufactures and markets outerwear, dresses, sportswear, swimwear, women's suits and performance wear, luggage, footwear, and women's handbags, leather goods, and cold we …
  • Aeglea BioTherapeutics Inc (AGLE)-製薬・医療分野:企業M&A・提携分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …
  • Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析
    Summary Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early ca …
  • APA Group:企業の戦略・SWOT・財務情報
    APA Group - Strategy, SWOT and Corporate Finance Report Summary APA Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • CAB Incorporated:企業の戦略的SWOT分析
    CAB Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company that develops medicines for rare diseases and unmet medical needs. The company’s pipeline products include NPC-09, NPC-12, NPC-15, NPC-16, NPC-17 and NPC-18. It offers products in the therapeutic areas of oncology, metabolic diseas …
  • Daiwa Securities Group Inc:企業の戦略・SWOT・財務分析
    Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report Summary Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Heska Corp (HSKA):企業の財務・戦略的SWOT分析
    Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆